Biomedical Production Technology

A strong value chain for the Netherlands

Lab-on-chip, organ-on-chip, artificial organs, and cell production technology: the Netherlands is not lacking in knowledge. What is missing, however, is a determined approach to transform this knowledge into groundbreaking products. With the NXTGEN Hightech program, we are making the difference in this area.

The challenge

From knowledge to production

The (academic) knowledge in the Netherlands is very high in the areas of Lab-on-Chip, Organ-on-Chip, Artificial Organs, and Cell Production Technology, but it is not (effectively) transformed into products. The main reason for this is the need for a multidisciplinary chain of suppliers of high-quality specialist components in both the technological and biological fields.

The strategy

A dynamic ecosystem

We can achieve this by connecting pieces of existing technology together, for example, for the production of chips, cells, bioactive materials. The companies already exist, but because they come from different fields, they sometimes do not yet speak the same language, let alone have technologies that interconnect seamlessly. Therefore, we are creating an ecosystem, an environment, where we collaborate intensively and align technologies with each other.

Our projects

These are the projects that are currently active within the Biomedical domain:

  • One-stop-shop

  • Lab-on-a-chip

  • Organ-on-a-chip

  • Artificial Organs

  • Cel production technology

Program Manager Biomed

Ingrid Relou

With her background in Biomedical Sciences, Ingrid has been active in new business development and program management in the Medical Technology & Life Sciences sector for over 20 years. Since 2014, she has been working for startups, scale-ups, and various stakeholders in the sector through her own company.

Let's connect

Want to know more about the NXTGEN Hightech-program? Contact us.